Cargando…

HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes

INTRODUCTION: Autoimmune diabetes has different clinical manifestations related to the age at onset. It is divided into several subtypes, including “classical” type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA). The LADA is considered a slowly progressing subtype of autoimmune dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Okruszko, Anna, Szepietowska, Barbara, Wawrusiewicz-Kurylonek, Natalia, Górska, Maria, Krętowski, Adam, Szelachowska, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506241/
https://www.ncbi.nlm.nih.gov/pubmed/23185198
http://dx.doi.org/10.5114/aoms.2012.31619
_version_ 1782250874358202368
author Okruszko, Anna
Szepietowska, Barbara
Wawrusiewicz-Kurylonek, Natalia
Górska, Maria
Krętowski, Adam
Szelachowska, Małgorzata
author_facet Okruszko, Anna
Szepietowska, Barbara
Wawrusiewicz-Kurylonek, Natalia
Górska, Maria
Krętowski, Adam
Szelachowska, Małgorzata
author_sort Okruszko, Anna
collection PubMed
description INTRODUCTION: Autoimmune diabetes has different clinical manifestations related to the age at onset. It is divided into several subtypes, including “classical” type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA). The LADA is considered a slowly progressing subtype of autoimmune diabetes, although the clinical picture is more similar to type 2 diabetes. MATERIAL AND METHODS: The aim of this study is to investigate whether genetic predisposition influences age at onset in autoimmune diabetes. We studied rs2476601 PTPN22 gene polymorphism and HLA DR, HLA-DQB1 in 175 patients with classical type 1 diabetes, 80 LADA, and 151 control subjects from north-east Poland. RESULTS: The frequencies of the PTPN22 TT genotype were higher in the group of patients with classical type 1 diabetes (6.3%) and LADA (11.3%) than in control subjects (0.7%) (p = 0.02 and p = 0007, respectively). In patients with classical type 1 diabetes we observed an increasing trend in frequencies of genotype TT dependent on age at onset (3.9% (0-5 year olds), 6.0% (6-15 year-olds), 8.2% (16-25 year olds), p = 0.048). The incidence of predisposing human leukocyte antigen (HLA) genotypes HLA DR3/DQB1*02 and DR4/DQB1*0302 was found to decrease in the group with type 1 diabetes in relation to age at onset and LADA (HLA DR3/DQB1*02 – 69.2% (0-5 year olds), 57.0% (6-15 year olds), 51.0% (16-25 year olds), 46.3% (LADA), p = 0.032; HLA DR4/DQB1*0302 – 80.8% (0-5 year olds), 63.0% (6-15 year olds), 51.0% (16-25 year olds), 43.8% (LADA), p = 0.0003), and to increase for the protective allele DQB1*0602 (0.0% (0-5 year olds), 1.0% (6-15 year olds), 2.0% (16-25 year olds), 6.3% (LADA), p = 0.029). CONCLUSIONS: Thus, age at onset for autoimmune diabetes appears to be related to a combination of predisposing and protective HLA alleles. Against a background of HLA genetic predisposition, other non-HLA loci may influence age at onset for late autoimmune diabetes.
format Online
Article
Text
id pubmed-3506241
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-35062412012-11-26 HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes Okruszko, Anna Szepietowska, Barbara Wawrusiewicz-Kurylonek, Natalia Górska, Maria Krętowski, Adam Szelachowska, Małgorzata Arch Med Sci Clinical Research INTRODUCTION: Autoimmune diabetes has different clinical manifestations related to the age at onset. It is divided into several subtypes, including “classical” type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA). The LADA is considered a slowly progressing subtype of autoimmune diabetes, although the clinical picture is more similar to type 2 diabetes. MATERIAL AND METHODS: The aim of this study is to investigate whether genetic predisposition influences age at onset in autoimmune diabetes. We studied rs2476601 PTPN22 gene polymorphism and HLA DR, HLA-DQB1 in 175 patients with classical type 1 diabetes, 80 LADA, and 151 control subjects from north-east Poland. RESULTS: The frequencies of the PTPN22 TT genotype were higher in the group of patients with classical type 1 diabetes (6.3%) and LADA (11.3%) than in control subjects (0.7%) (p = 0.02 and p = 0007, respectively). In patients with classical type 1 diabetes we observed an increasing trend in frequencies of genotype TT dependent on age at onset (3.9% (0-5 year olds), 6.0% (6-15 year-olds), 8.2% (16-25 year olds), p = 0.048). The incidence of predisposing human leukocyte antigen (HLA) genotypes HLA DR3/DQB1*02 and DR4/DQB1*0302 was found to decrease in the group with type 1 diabetes in relation to age at onset and LADA (HLA DR3/DQB1*02 – 69.2% (0-5 year olds), 57.0% (6-15 year olds), 51.0% (16-25 year olds), 46.3% (LADA), p = 0.032; HLA DR4/DQB1*0302 – 80.8% (0-5 year olds), 63.0% (6-15 year olds), 51.0% (16-25 year olds), 43.8% (LADA), p = 0.0003), and to increase for the protective allele DQB1*0602 (0.0% (0-5 year olds), 1.0% (6-15 year olds), 2.0% (16-25 year olds), 6.3% (LADA), p = 0.029). CONCLUSIONS: Thus, age at onset for autoimmune diabetes appears to be related to a combination of predisposing and protective HLA alleles. Against a background of HLA genetic predisposition, other non-HLA loci may influence age at onset for late autoimmune diabetes. Termedia Publishing House 2012-11-07 2012-11-09 /pmc/articles/PMC3506241/ /pubmed/23185198 http://dx.doi.org/10.5114/aoms.2012.31619 Text en Copyright © 2012 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Okruszko, Anna
Szepietowska, Barbara
Wawrusiewicz-Kurylonek, Natalia
Górska, Maria
Krętowski, Adam
Szelachowska, Małgorzata
HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
title HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
title_full HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
title_fullStr HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
title_full_unstemmed HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
title_short HLA-DR, HLA-DQB1 and PTPN22 gene polymorphism: association with age at onset for autoimmune diabetes
title_sort hla-dr, hla-dqb1 and ptpn22 gene polymorphism: association with age at onset for autoimmune diabetes
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506241/
https://www.ncbi.nlm.nih.gov/pubmed/23185198
http://dx.doi.org/10.5114/aoms.2012.31619
work_keys_str_mv AT okruszkoanna hladrhladqb1andptpn22genepolymorphismassociationwithageatonsetforautoimmunediabetes
AT szepietowskabarbara hladrhladqb1andptpn22genepolymorphismassociationwithageatonsetforautoimmunediabetes
AT wawrusiewiczkuryloneknatalia hladrhladqb1andptpn22genepolymorphismassociationwithageatonsetforautoimmunediabetes
AT gorskamaria hladrhladqb1andptpn22genepolymorphismassociationwithageatonsetforautoimmunediabetes
AT kretowskiadam hladrhladqb1andptpn22genepolymorphismassociationwithageatonsetforautoimmunediabetes
AT szelachowskamałgorzata hladrhladqb1andptpn22genepolymorphismassociationwithageatonsetforautoimmunediabetes